James L. Perhach

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

George T. Grossberg, Facundo Manes, Ricardo Allegri et al. · CNS Drugs · 2013 · 158 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A sensitive, rapid and simple method for the simultaneous spectrophotofluorometric determinations of norepinephrine, dopamine, 5‐hydroxytryptamine and 5‐hydroxyindoleacetic acid in discrete areas of brain

Raymond H. Cox, James L. Perhach · Journal of Neurochemistry · 1973 · 157 citations

Life Sciences, Neurobiology, Neuroscience +6

Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: Implications for its mode of action

Naresh Chand, John Pillar, William Diamantis et al. · European Journal of Pharmacology · 1983 · 122 citations

Life Sciences, Immunology, Pharmacology +13

Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension

Michael G. Aman, Robert L. Findling, Antonio Y. Hardan et al. · Journal of Child and Adolescent Psychopharmacology · 2016 · 103 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Corticosterone elevation mediated centrally by Δ1-tetrahydrocannabinol in rats

Robert K. Kubena, James L. Perhach, Herbert Barry · European Journal of Pharmacology · 1971 · 91 citations

Medicine, Neuroscience, Pharmacology +10